Global FIS1 Antibody Market Growth (Status and Outlook) 2026-2032

May 2026 | 125 pages | ID: GB0DDB654F56EN
LP Information

Abstracts

The global FIS1 Antibody market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

United States market for FIS1 Antibody is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for FIS1 Antibody is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for FIS1 Antibody is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key FIS1 Antibody players cover Merck, Bioss, Thermo Fisher Scientific, Novus Biologicals, GeneTex, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LPI (LP Information)' newest research report, the “FIS1 Antibody Industry Forecast” looks at past sales and reviews total world FIS1 Antibody sales in 2025, providing a comprehensive analysis by region and market sector of projected FIS1 Antibody sales for 2026 through 2032. With FIS1 Antibody sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world FIS1 Antibody industry.

This Insight Report provides a comprehensive analysis of the global FIS1 Antibody landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on FIS1 Antibody portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global FIS1 Antibody market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for FIS1 Antibody and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global FIS1 Antibody.

This report presents a comprehensive overview, market shares, and growth opportunities of FIS1 Antibody market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Monoclonal
• Polyclonal

Segmentation by Application:

• Immunochemistry (IHC)
• Immunofluorescence (IF)
• Immunoprecipitation (IP)
• Western Blot (WB)
• ELISA
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Merck
• Bioss
• Thermo Fisher Scientific
• Novus Biologicals
• GeneTex
• Enzo Life Sciences, Inc.
• RayBiotech
• LifeSpan BioSciences
• Leading Biology
• ProSci
• Abcam
• OriGene Technologies
• NSJ Bioreagents
• Affinity Biosciences
• Biobyt
• Jingjie PTM BioLab
• Beijing Solarbio

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global FIS1 Antibody Market Size (2021-2032)
  2.1.2 FIS1 Antibody Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for FIS1 Antibody by Country/Region (2021, 2025 & 2032)
2.2 FIS1 Antibody Segment by Type
  2.2.1 Monoclonal
  2.2.2 Polyclonal
  2.2.3 FIS1 Antibody Market Size by Type
    2.2.3.1 FIS1 Antibody Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.3.2 Global FIS1 Antibody Market Size Market Share by Type (2021-2026)
2.3 FIS1 Antibody Segment by Application
  2.3.1 Immunochemistry (IHC)
  2.3.2 Immunofluorescence (IF)
  2.3.3 Immunoprecipitation (IP)
  2.3.4 Western Blot (WB)
  2.3.5 ELISA
  2.3.6 Others
  2.3.7 FIS1 Antibody Market Size by Application
    2.3.7.1 FIS1 Antibody Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.3.7.2 Global FIS1 Antibody Market Size Market Share by Application (2021-2026)

3 FIS1 ANTIBODY MARKET SIZE BY PLAYER

3.1 FIS1 Antibody Market Size Market Share by Player
  3.1.1 Global FIS1 Antibody Revenue by Player (2021-2026)
  3.1.2 Global FIS1 Antibody Revenue Market Share by Player (2021-2026)
3.2 Global FIS1 Antibody Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 FIS1 ANTIBODY BY REGION

4.1 FIS1 Antibody Market Size by Region (2021-2026)
4.2 Global FIS1 Antibody Annual Revenue by Country/Region (2021-2026)
4.3 Americas FIS1 Antibody Market Size Growth (2021-2026)
4.4 APAC FIS1 Antibody Market Size Growth (2021-2026)
4.5 Europe FIS1 Antibody Market Size Growth (2021-2026)
4.6 Middle East & Africa FIS1 Antibody Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas FIS1 Antibody Market Size by Country (2021-2026)
5.2 Americas FIS1 Antibody Market Size by Type (2021-2026)
5.3 Americas FIS1 Antibody Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC FIS1 Antibody Market Size by Region (2021-2026)
6.2 APAC FIS1 Antibody Market Size by Type (2021-2026)
6.3 APAC FIS1 Antibody Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe FIS1 Antibody Market Size by Country (2021-2026)
7.2 Europe FIS1 Antibody Market Size by Type (2021-2026)
7.3 Europe FIS1 Antibody Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa FIS1 Antibody by Region (2021-2026)
8.2 Middle East & Africa FIS1 Antibody Market Size by Type (2021-2026)
8.3 Middle East & Africa FIS1 Antibody Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL FIS1 ANTIBODY MARKET FORECAST

10.1 Global FIS1 Antibody Forecast by Region (2027-2032)
  10.1.1 Global FIS1 Antibody Forecast by Region (2027-2032)
  10.1.2 Americas FIS1 Antibody Forecast
  10.1.3 APAC FIS1 Antibody Forecast
  10.1.4 Europe FIS1 Antibody Forecast
  10.1.5 Middle East & Africa FIS1 Antibody Forecast
10.2 Americas FIS1 Antibody Forecast by Country (2027-2032)
  10.2.1 United States Market FIS1 Antibody Forecast
  10.2.2 Canada Market FIS1 Antibody Forecast
  10.2.3 Mexico Market FIS1 Antibody Forecast
  10.2.4 Brazil Market FIS1 Antibody Forecast
10.3 APAC FIS1 Antibody Forecast by Region (2027-2032)
  10.3.1 China FIS1 Antibody Market Forecast
  10.3.2 Japan Market FIS1 Antibody Forecast
  10.3.3 Korea Market FIS1 Antibody Forecast
  10.3.4 Southeast Asia Market FIS1 Antibody Forecast
  10.3.5 India Market FIS1 Antibody Forecast
  10.3.6 Australia Market FIS1 Antibody Forecast
10.4 Europe FIS1 Antibody Forecast by Country (2027-2032)
  10.4.1 Germany Market FIS1 Antibody Forecast
  10.4.2 France Market FIS1 Antibody Forecast
  10.4.3 UK Market FIS1 Antibody Forecast
  10.4.4 Italy Market FIS1 Antibody Forecast
  10.4.5 Russia Market FIS1 Antibody Forecast
10.5 Middle East & Africa FIS1 Antibody Forecast by Region (2027-2032)
  10.5.1 Egypt Market FIS1 Antibody Forecast
  10.5.2 South Africa Market FIS1 Antibody Forecast
  10.5.3 Israel Market FIS1 Antibody Forecast
  10.5.4 Turkey Market FIS1 Antibody Forecast
10.6 Global FIS1 Antibody Forecast by Type (2027-2032)
10.7 Global FIS1 Antibody Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market FIS1 Antibody Forecast

11 KEY PLAYERS ANALYSIS

11.1 Merck
  11.1.1 Merck Company Information
  11.1.2 Merck FIS1 Antibody Product Offered
  11.1.3 Merck FIS1 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 Merck Main Business Overview
  11.1.5 Merck Latest Developments
11.2 Bioss
  11.2.1 Bioss Company Information
  11.2.2 Bioss FIS1 Antibody Product Offered
  11.2.3 Bioss FIS1 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 Bioss Main Business Overview
  11.2.5 Bioss Latest Developments
11.3 Thermo Fisher Scientific
  11.3.1 Thermo Fisher Scientific Company Information
  11.3.2 Thermo Fisher Scientific FIS1 Antibody Product Offered
  11.3.3 Thermo Fisher Scientific FIS1 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 Thermo Fisher Scientific Main Business Overview
  11.3.5 Thermo Fisher Scientific Latest Developments
11.4 Novus Biologicals
  11.4.1 Novus Biologicals Company Information
  11.4.2 Novus Biologicals FIS1 Antibody Product Offered
  11.4.3 Novus Biologicals FIS1 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 Novus Biologicals Main Business Overview
  11.4.5 Novus Biologicals Latest Developments
11.5 GeneTex
  11.5.1 GeneTex Company Information
  11.5.2 GeneTex FIS1 Antibody Product Offered
  11.5.3 GeneTex FIS1 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.5.4 GeneTex Main Business Overview
  11.5.5 GeneTex Latest Developments
11.6 Enzo Life Sciences, Inc.
  11.6.1 Enzo Life Sciences, Inc. Company Information
  11.6.2 Enzo Life Sciences, Inc. FIS1 Antibody Product Offered
  11.6.3 Enzo Life Sciences, Inc. FIS1 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.6.4 Enzo Life Sciences, Inc. Main Business Overview
  11.6.5 Enzo Life Sciences, Inc. Latest Developments
11.7 RayBiotech
  11.7.1 RayBiotech Company Information
  11.7.2 RayBiotech FIS1 Antibody Product Offered
  11.7.3 RayBiotech FIS1 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.7.4 RayBiotech Main Business Overview
  11.7.5 RayBiotech Latest Developments
11.8 LifeSpan BioSciences
  11.8.1 LifeSpan BioSciences Company Information
  11.8.2 LifeSpan BioSciences FIS1 Antibody Product Offered
  11.8.3 LifeSpan BioSciences FIS1 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.8.4 LifeSpan BioSciences Main Business Overview
  11.8.5 LifeSpan BioSciences Latest Developments
11.9 Leading Biology
  11.9.1 Leading Biology Company Information
  11.9.2 Leading Biology FIS1 Antibody Product Offered
  11.9.3 Leading Biology FIS1 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.9.4 Leading Biology Main Business Overview
  11.9.5 Leading Biology Latest Developments
11.10 ProSci
  11.10.1 ProSci Company Information
  11.10.2 ProSci FIS1 Antibody Product Offered
  11.10.3 ProSci FIS1 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.10.4 ProSci Main Business Overview
  11.10.5 ProSci Latest Developments
11.11 Abcam
  11.11.1 Abcam Company Information
  11.11.2 Abcam FIS1 Antibody Product Offered
  11.11.3 Abcam FIS1 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.11.4 Abcam Main Business Overview
  11.11.5 Abcam Latest Developments
11.12 OriGene Technologies
  11.12.1 OriGene Technologies Company Information
  11.12.2 OriGene Technologies FIS1 Antibody Product Offered
  11.12.3 OriGene Technologies FIS1 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.12.4 OriGene Technologies Main Business Overview
  11.12.5 OriGene Technologies Latest Developments
11.13 NSJ Bioreagents
  11.13.1 NSJ Bioreagents Company Information
  11.13.2 NSJ Bioreagents FIS1 Antibody Product Offered
  11.13.3 NSJ Bioreagents FIS1 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.13.4 NSJ Bioreagents Main Business Overview
  11.13.5 NSJ Bioreagents Latest Developments
11.14 Affinity Biosciences
  11.14.1 Affinity Biosciences Company Information
  11.14.2 Affinity Biosciences FIS1 Antibody Product Offered
  11.14.3 Affinity Biosciences FIS1 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.14.4 Affinity Biosciences Main Business Overview
  11.14.5 Affinity Biosciences Latest Developments
11.15 Biobyt
  11.15.1 Biobyt Company Information
  11.15.2 Biobyt FIS1 Antibody Product Offered
  11.15.3 Biobyt FIS1 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.15.4 Biobyt Main Business Overview
  11.15.5 Biobyt Latest Developments
11.16 Jingjie PTM BioLab
  11.16.1 Jingjie PTM BioLab Company Information
  11.16.2 Jingjie PTM BioLab FIS1 Antibody Product Offered
  11.16.3 Jingjie PTM BioLab FIS1 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.16.4 Jingjie PTM BioLab Main Business Overview
  11.16.5 Jingjie PTM BioLab Latest Developments
11.17 Beijing Solarbio
  11.17.1 Beijing Solarbio Company Information
  11.17.2 Beijing Solarbio FIS1 Antibody Product Offered
  11.17.3 Beijing Solarbio FIS1 Antibody Revenue, Gross Margin and Market Share (2021-2026)
  11.17.4 Beijing Solarbio Main Business Overview
  11.17.5 Beijing Solarbio Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. FIS1 Antibody Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. FIS1 Antibody Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Monoclonal
Table 4. Major Players of Polyclonal
Table 5. FIS1 Antibody Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global FIS1 Antibody Market Size by Type (2021-2026) & ($ millions)
Table 7. Global FIS1 Antibody Market Size Market Share by Type (2021-2026)
Table 8. FIS1 Antibody Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global FIS1 Antibody Market Size by Application (2021-2026) & ($ millions)
Table 10. Global FIS1 Antibody Market Size Market Share by Application (2021-2026)
Table 11. Global FIS1 Antibody Revenue by Player (2021-2026) & ($ millions)
Table 12. Global FIS1 Antibody Revenue Market Share by Player (2021-2026)
Table 13. FIS1 Antibody Key Players Head office and Products Offered
Table 14. FIS1 Antibody Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global FIS1 Antibody Market Size by Region (2021-2026) & ($ millions)
Table 18. Global FIS1 Antibody Market Size Market Share by Region (2021-2026)
Table 19. Global FIS1 Antibody Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global FIS1 Antibody Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas FIS1 Antibody Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas FIS1 Antibody Market Size Market Share by Country (2021-2026)
Table 23. Americas FIS1 Antibody Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas FIS1 Antibody Market Size Market Share by Type (2021-2026)
Table 25. Americas FIS1 Antibody Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas FIS1 Antibody Market Size Market Share by Application (2021-2026)
Table 27. APAC FIS1 Antibody Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC FIS1 Antibody Market Size Market Share by Region (2021-2026)
Table 29. APAC FIS1 Antibody Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC FIS1 Antibody Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe FIS1 Antibody Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe FIS1 Antibody Market Size Market Share by Country (2021-2026)
Table 33. Europe FIS1 Antibody Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe FIS1 Antibody Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa FIS1 Antibody Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa FIS1 Antibody Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa FIS1 Antibody Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of FIS1 Antibody
Table 39. Key Market Challenges & Risks of FIS1 Antibody
Table 40. Key Industry Trends of FIS1 Antibody
Table 41. Global FIS1 Antibody Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global FIS1 Antibody Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global FIS1 Antibody Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global FIS1 Antibody Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Merck Details, Company Type, FIS1 Antibody Area Served and Its Competitors
Table 46. Merck FIS1 Antibody Product Offered
Table 47. Merck FIS1 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Merck Main Business
Table 49. Merck Latest Developments
Table 50. Bioss Details, Company Type, FIS1 Antibody Area Served and Its Competitors
Table 51. Bioss FIS1 Antibody Product Offered
Table 52. Bioss FIS1 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Bioss Main Business
Table 54. Bioss Latest Developments
Table 55. Thermo Fisher Scientific Details, Company Type, FIS1 Antibody Area Served and Its Competitors
Table 56. Thermo Fisher Scientific FIS1 Antibody Product Offered
Table 57. Thermo Fisher Scientific FIS1 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Thermo Fisher Scientific Main Business
Table 59. Thermo Fisher Scientific Latest Developments
Table 60. Novus Biologicals Details, Company Type, FIS1 Antibody Area Served and Its Competitors
Table 61. Novus Biologicals FIS1 Antibody Product Offered
Table 62. Novus Biologicals FIS1 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Novus Biologicals Main Business
Table 64. Novus Biologicals Latest Developments
Table 65. GeneTex Details, Company Type, FIS1 Antibody Area Served and Its Competitors
Table 66. GeneTex FIS1 Antibody Product Offered
Table 67. GeneTex FIS1 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. GeneTex Main Business
Table 69. GeneTex Latest Developments
Table 70. Enzo Life Sciences, Inc. Details, Company Type, FIS1 Antibody Area Served and Its Competitors
Table 71. Enzo Life Sciences, Inc. FIS1 Antibody Product Offered
Table 72. Enzo Life Sciences, Inc. FIS1 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Enzo Life Sciences, Inc. Main Business
Table 74. Enzo Life Sciences, Inc. Latest Developments
Table 75. RayBiotech Details, Company Type, FIS1 Antibody Area Served and Its Competitors
Table 76. RayBiotech FIS1 Antibody Product Offered
Table 77. RayBiotech FIS1 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. RayBiotech Main Business
Table 79. RayBiotech Latest Developments
Table 80. LifeSpan BioSciences Details, Company Type, FIS1 Antibody Area Served and Its Competitors
Table 81. LifeSpan BioSciences FIS1 Antibody Product Offered
Table 82. LifeSpan BioSciences FIS1 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. LifeSpan BioSciences Main Business
Table 84. LifeSpan BioSciences Latest Developments
Table 85. Leading Biology Details, Company Type, FIS1 Antibody Area Served and Its Competitors
Table 86. Leading Biology FIS1 Antibody Product Offered
Table 87. Leading Biology FIS1 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Leading Biology Main Business
Table 89. Leading Biology Latest Developments
Table 90. ProSci Details, Company Type, FIS1 Antibody Area Served and Its Competitors
Table 91. ProSci FIS1 Antibody Product Offered
Table 92. ProSci FIS1 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. ProSci Main Business
Table 94. ProSci Latest Developments
Table 95. Abcam Details, Company Type, FIS1 Antibody Area Served and Its Competitors
Table 96. Abcam FIS1 Antibody Product Offered
Table 97. Abcam FIS1 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Abcam Main Business
Table 99. Abcam Latest Developments
Table 100. OriGene Technologies Details, Company Type, FIS1 Antibody Area Served and Its Competitors
Table 101. OriGene Technologies FIS1 Antibody Product Offered
Table 102. OriGene Technologies FIS1 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. OriGene Technologies Main Business
Table 104. OriGene Technologies Latest Developments
Table 105. NSJ Bioreagents Details, Company Type, FIS1 Antibody Area Served and Its Competitors
Table 106. NSJ Bioreagents FIS1 Antibody Product Offered
Table 107. NSJ Bioreagents FIS1 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. NSJ Bioreagents Main Business
Table 109. NSJ Bioreagents Latest Developments
Table 110. Affinity Biosciences Details, Company Type, FIS1 Antibody Area Served and Its Competitors
Table 111. Affinity Biosciences FIS1 Antibody Product Offered
Table 112. Affinity Biosciences FIS1 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. Affinity Biosciences Main Business
Table 114. Affinity Biosciences Latest Developments
Table 115. Biobyt Details, Company Type, FIS1 Antibody Area Served and Its Competitors
Table 116. Biobyt FIS1 Antibody Product Offered
Table 117. Biobyt FIS1 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 118. Biobyt Main Business
Table 119. Biobyt Latest Developments
Table 120. Jingjie PTM BioLab Details, Company Type, FIS1 Antibody Area Served and Its Competitors
Table 121. Jingjie PTM BioLab FIS1 Antibody Product Offered
Table 122. Jingjie PTM BioLab FIS1 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 123. Jingjie PTM BioLab Main Business
Table 124. Jingjie PTM BioLab Latest Developments
Table 125. Beijing Solarbio Details, Company Type, FIS1 Antibody Area Served and Its Competitors
Table 126. Beijing Solarbio FIS1 Antibody Product Offered
Table 127. Beijing Solarbio FIS1 Antibody Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 128. Beijing Solarbio Main Business
Table 129. Beijing Solarbio Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. FIS1 Antibody Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global FIS1 Antibody Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. FIS1 Antibody Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. FIS1 Antibody Sales Market Share by Country/Region (2025)
Figure 8. FIS1 Antibody Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global FIS1 Antibody Market Size Market Share by Type in 2025
Figure 10. FIS1 Antibody in Immunochemistry (IHC)
Figure 11. Global FIS1 Antibody Market: Immunochemistry (IHC) (2021-2026) & ($ millions)
Figure 12. FIS1 Antibody in Immunofluorescence (IF)
Figure 13. Global FIS1 Antibody Market: Immunofluorescence (IF) (2021-2026) & ($ millions)
Figure 14. FIS1 Antibody in Immunoprecipitation (IP)
Figure 15. Global FIS1 Antibody Market: Immunoprecipitation (IP) (2021-2026) & ($ millions)
Figure 16. FIS1 Antibody in Western Blot (WB)
Figure 17. Global FIS1 Antibody Market: Western Blot (WB) (2021-2026) & ($ millions)
Figure 18. FIS1 Antibody in ELISA
Figure 19. Global FIS1 Antibody Market: ELISA (2021-2026) & ($ millions)
Figure 20. FIS1 Antibody in Others
Figure 21. Global FIS1 Antibody Market: Others (2021-2026) & ($ millions)
Figure 22. Global FIS1 Antibody Market Size Market Share by Application in 2025
Figure 23. Global FIS1 Antibody Revenue Market Share by Player in 2025
Figure 24. Global FIS1 Antibody Market Size Market Share by Region (2021-2026)
Figure 25. Americas FIS1 Antibody Market Size 2021-2026 ($ millions)
Figure 26. APAC FIS1 Antibody Market Size 2021-2026 ($ millions)
Figure 27. Europe FIS1 Antibody Market Size 2021-2026 ($ millions)
Figure 28. Middle East & Africa FIS1 Antibody Market Size 2021-2026 ($ millions)
Figure 29. Americas FIS1 Antibody Value Market Share by Country in 2025
Figure 30. United States FIS1 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 31. Canada FIS1 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 32. Mexico FIS1 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 33. Brazil FIS1 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 34. APAC FIS1 Antibody Market Size Market Share by Region in 2025
Figure 35. APAC FIS1 Antibody Market Size Market Share by Type (2021-2026)
Figure 36. APAC FIS1 Antibody Market Size Market Share by Application (2021-2026)
Figure 37. China FIS1 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 38. Japan FIS1 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 39. South Korea FIS1 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 40. Southeast Asia FIS1 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 41. India FIS1 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 42. Australia FIS1 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 43. Europe FIS1 Antibody Market Size Market Share by Country in 2025
Figure 44. Europe FIS1 Antibody Market Size Market Share by Type (2021-2026)
Figure 45. Europe FIS1 Antibody Market Size Market Share by Application (2021-2026)
Figure 46. Germany FIS1 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 47. France FIS1 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 48. UK FIS1 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 49. Italy FIS1 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 50. Russia FIS1 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 51. Middle East & Africa FIS1 Antibody Market Size Market Share by Region (2021-2026)
Figure 52. Middle East & Africa FIS1 Antibody Market Size Market Share by Type (2021-2026)
Figure 53. Middle East & Africa FIS1 Antibody Market Size Market Share by Application (2021-2026)
Figure 54. Egypt FIS1 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 55. South Africa FIS1 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 56. Israel FIS1 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 57. Turkey FIS1 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 58. GCC Countries FIS1 Antibody Market Size Growth 2021-2026 ($ millions)
Figure 59. Americas FIS1 Antibody Market Size 2027-2032 ($ millions)
Figure 60. APAC FIS1 Antibody Market Size 2027-2032 ($ millions)
Figure 61. Europe FIS1 Antibody Market Size 2027-2032 ($ millions)
Figure 62. Middle East & Africa FIS1 Antibody Market Size 2027-2032 ($ millions)
Figure 63. United States FIS1 Antibody Market Size 2027-2032 ($ millions)
Figure 64. Canada FIS1 Antibody Market Size 2027-2032 ($ millions)
Figure 65. Mexico FIS1 Antibody Market Size 2027-2032 ($ millions)
Figure 66. Brazil FIS1 Antibody Market Size 2027-2032 ($ millions)
Figure 67. China FIS1 Antibody Market Size 2027-2032 ($ millions)
Figure 68. Japan FIS1 Antibody Market Size 2027-2032 ($ millions)
Figure 69. Korea FIS1 Antibody Market Size 2027-2032 ($ millions)
Figure 70. Southeast Asia FIS1 Antibody Market Size 2027-2032 ($ millions)
Figure 71. India FIS1 Antibody Market Size 2027-2032 ($ millions)
Figure 72. Australia FIS1 Antibody Market Size 2027-2032 ($ millions)
Figure 73. Germany FIS1 Antibody Market Size 2027-2032 ($ millions)
Figure 74. France FIS1 Antibody Market Size 2027-2032 ($ millions)
Figure 75. UK FIS1 Antibody Market Size 2027-2032 ($ millions)
Figure 76. Italy FIS1 Antibody Market Size 2027-2032 ($ millions)
Figure 77. Russia FIS1 Antibody Market Size 2027-2032 ($ millions)
Figure 78. Egypt FIS1 Antibody Market Size 2027-2032 ($ millions)
Figure 79. South Africa FIS1 Antibody Market Size 2027-2032 ($ millions)
Figure 80. Israel FIS1 Antibody Market Size 2027-2032 ($ millions)
Figure 81. Turkey FIS1 Antibody Market Size 2027-2032 ($ millions)
Figure 82. Global FIS1 Antibody Market Size Market Share Forecast by Type (2027-2032)
Figure 83. Global FIS1 Antibody Market Size Market Share Forecast by Application (2027-2032)
Figure 84. GCC Countries FIS1 Antibody Market Size 2027-2032 ($ millions)